{"SPADE_UN_16899": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16899", "Peptide Name": "Buforin-2 (5-13)[17-20]2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "RAGLQFPVGRLLRRLLR", "Sequence Length": 17, "UniProt Entry": ["http://www.uniprot.org/uniprot/P55897"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C91H161N33O19", "Mass": 2021.46, "PI": 12.0, "Net Charge": 5, "Hydrophobicity": -0.04, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Literature": [{"Title": "A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells", "Pubmed ID": "23776609", "Reference": "PLoS One. 2013 Jun 11;8(6)e66084.", "Author": "Lim KJ, Sung BH, Shin JR, Lee YW, Kim DJ, Yang KS, Kim SC.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23776609"}], "Frequent Amino Acids": "LRG", "Absent Amino Acids": "CDEHIKMNOSTUWY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 8, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_00772", "Similarity": 1.0, "Sequence": "RAGLQFPVGRLLRRLLRRLLR"}, {"SPADE_ID": "SPADE_UN_07993", "Similarity": 1.0, "Sequence": "GRAGLQFPVGRLLRRLLRRLLR"}, {"SPADE_ID": "SPADE_UN_13370", "Similarity": 1.0, "Sequence": "AGLQFP"}]}}}